What Trump can do to boost the US medical device industry
Precision Neuroscience Co-Founder and CEO Michael Mager discusses the changes coming to the healthcare and technology sectors under a second Trump administration at the Yahoo Finance Invest conference. In an interview with Yahoo Finance's Yasmin Khorram, Mager reflects on the possibility that Elon Musk, the CEO of Precision’s direct competitor Neuralink, will be a part of President-elect Donald Trump’s inner circle, saying it’s "no bad thing” having someone like Musk, who understands the tech, at a senior level in government. Despite Musk's involvement, Mager doesn't think his industry needs a boost: "We, as an industry, don't need any special favors or treatment." To watch live and see every interview from Yahoo Finance Invest, click here. See the full interview with Michael Mager by clicking here. This post was written by Conor White.